Altered RNA turnover in carcinogenesis
- 94 Downloads
Excretion of urinary modified nucleosides is frequently elevated in patients with oncogenic disease. Increases of urinary pseudouridine excretion are now demonstrated in patients with a variety of brain tumors. The potential use of urinary modified base excretion as a cancer marker is discussed and possible sources of the elevated nucleosides are detailed. The specific steps in RNA metabolism that result in increased levels of RNA nucleoside excretion are poorly understood. This knowledge will be necessary to understand the molecular mechanism and the clinical significance of urinary nucleoside excretion in treatment and diagnosis of oncogenic disease.
Index EntriesUrinary nucleosides urinary excretion modified nucleosides tumor markers RNA tRNA pseudouridine
Unable to display preview. Download preview PDF.
- Clark I., MacKenzie J. W., McCoy J. R., and Lin W. (1983) Comparison of urinary modified nucleosides and bases in rats with hepatomas and nephroblastomas, inRecent Results in Cancer Research. Springer-Verlag, Berlin, p. 388–400.Google Scholar
- Gehrke C. W. and Kuo K. C. T. (eds.) (1990a)Chromatography and Modification of Nucleosides part C Modified nucleosides in cancer and normal metabolism methods and applications. J. Chromatog. Elsevier, Amsterdam.Google Scholar
- Gehrke C. W. and Kuo K. C. T. (eds.), (1990b)Chromatography and Modification of Nucleosides part D A Comprehensive Database for tRNA and Nucleosides-HPLC, GC, MS, UV, and FT-IR. J. Chromatog. Elsevier, Amsterdam.Google Scholar
- Heldman D. A., Grever M. R., Miser J. S., and Trewyn R. W. (1983a) Relationship of urinary excretion of modified nucleosides to disease status in childhood acute lymphoblastic leukemia.J. Nat. Cancer Ins. 71, 269–273.Google Scholar
- Nass G. (ed.) (1983)Modified Nucleosides and Cancer (Recent Results in Cancer Research), Springer-Verlag, Berlin.Google Scholar
- Randerath K., Tseng W.-C., Harris J. S., and Lu L.-J. W. (1983) Specific effects of 5-fluoropyrimidines and 5-azapyrimidines on modification of the 5 position of pyrimidines, in particular the synthesis of 5-methyluracil and 5-methylcytosine in nucleic acids, inRecent Results in Cancer Research Modified Nucleosides and Cancer. Springer-Verlag, Berlin, pp. 283–297.Google Scholar
- Rasmuson T. and Björk G. R. (1985) Excretion of pseudouridine in urine as a tumor marker in malignant diseases.Bull. Mol. Biol. Med. 10, 143–154.Google Scholar
- Schoch G., Sander G., Topp H., and Heller-Schoch G. (1990) Modified nucleosides and nucleobases in urine and serum as selective markers for the whole-body turnover of tRNA, rRNA, and mRNA: Future prospects and impact, inChromatography and modification of nucleosides part C Modified nucleosides in cancer and normal metabolism methods and applications, Elsevier, Amsterdam, pp. C389-C442.CrossRefGoogle Scholar
- Vold B. S., Keith Jr. D. E., and Slavik M. (1982) Urine levels of N-[9-(B-D-ribofuranosyl) (purin-6-y)carbamoyl]-L-threanine, N6-(delta2-isopentenyl)adenosine, and 2′-O-methylguanosine as determined by radioimmunoassay for normal subjects and cancer patients.Cancer Res. 42, 5265–5269.PubMedGoogle Scholar